The company said, “Fourth quarter 2025 reported preliminary unaudited revenue in the range of approximately $389 million to $395 million, up approximately 10% to 11% year-over-year.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical chair Fred Lampropoulos resigns, F. Ann Millner succeeds
- Merit Medical price target raised to $99 from $93 at Canaccord
- Merit Medical price target raised to $108 from $103 at Baird
- Hold Rating for Merit Medical Systems Due to Pending Long-term Data and Pricing Challenges for WRAPSODY Stent
- Merit Medical price target lowered to $93 from $104 at Canaccord